Medicare will begin paying later this year for certain oral cancer drugs and intravenous drugs that can be self-administered under a $500 million demonstration project unveiled yesterday.
Medicare plans for the project to go into effect today.
( z1 plan :ARG0 ( z2 program :name ( z3 name :op "Medicare" ) ) :ARG1 ( z4 effect :ARG1 ( z5 project ) :time ( z6 today ) ) )